Koya Medical CEO Andy Doraiswamy to Speak at The MedTech Conference 2025 in San Diego

DALLAS and SAN DIEGO, Oct. 7, 2025 /PRNewswire/ -- Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered solutions in vascular health, announced today that CEO Andy Doraiswamy will participate in The MedTech Conference 2025, taking place October 5–8 in San Diego. Doraiswamy will join a high-profile panel on October 7 at 2:00pm addressing "Maximizing Value Through Smart Reimbursement Strategies"—a critical factor for both patient access and scalable growth in medical innovation.

The MedTech Conference is a premier global event where healthcare executives, investors, and policymakers convene to explore new technologies, commercialization pathways, and strategies shaping the future of healthcare.

"This conference is more than a venue for innovation—it's where transformative ideas gain the strategic pathways needed to drive market adoption, generate measurable impact, and ultimately improve patient outcomes at scale," said Andy Doraiswamy. "Our mission at Koya is to deliver solutions that not only demonstrate clinical excellence but also align with the economic realities of reimbursement, adoption, and large-scale deployment across the continuum of vascular care," said Charles Liu, Chief Strategy & Marketing Officer.

Conference attendees can engage with Koya through one-on-one networking sessions and learn more about the company's products and pipeline, market access strategy, and progress in vascular health—an area with significant unmet needs and long-term growth opportunity.

About Koya Medical

Founded in 2018 and headquartered in Dallas, Koya Medical is redefining vascular health with patient-centered solutions designed to support care from clinic to home. Inspired by a personal journey with vascular disease, Koya's mission is to close treatment gaps —starting with its FDA-cleared Dayspring treatment system and advancing its pipeline.

Why Vascular Health Matters

More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—highlighting the urgent need for modern, evidence-based, and scalable solutions.

Learn more at www.koyamedical.com and follow Koya on LinkedIn.

SOURCE Koya Medical